White Papers

  1. Faster Starts, Stronger Finish: Operational Excellence In NSCLC 5/22/2026

    In NSCLC trials, data‑driven site selection, streamlined protocols, efficient screening strategies, and proactive engagement can accelerate enrollment and improve trial efficiency across regions.

  2. How Adaptive Design Accelerates Early‑Phase NSCLC Development 5/22/2026

    Adaptive trial designs and an adaptive mindset enable non-small cell lung cancer (NSCLC) sponsors to optimize dose, respond to evolving expectations, and accelerate early‑phase development.

  3. Rethinking Trial Access Through Trust-Driven Design And Local Collaboration 5/19/2026

    Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.

  4. Reduce Avoidable Protocol Amendments By Anticipating Operational Pitfalls 5/13/2026

    This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

  5. 5 Questions To Ask Before Selecting A Randomization Partner 5/12/2026

    Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.

  6. State of Materiovigilance: Gaps, Technology & Outsourcing 5/12/2026

    Explore how pharma and biotech companies are using AI, outsourcing, and new technologies to strengthen materiovigilance for complex drug-device products.

  7. Reducing Inventory Errors In Clinical Trials 5/8/2026

    Can a digital double-check save your trial from data errors? How does verifying shipments at receipt slash inventory mistakes? Learn to protect protocol integrity and patient safety.

  8. Go From Three Meetings To One With AI-Enabled eCOA 5/5/2026

    Learn how to turn three meetings into one with AI that is streamlining clinical workflows by reducing redundant steps, simplifying site operations, and accelerating data collection.

  9. US Healthcare System Overview 4/29/2026

    A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.

  10. Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere 4/27/2026

    Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.